Register entry

Anhui Haoyuan Pharmaceutical Co., Ltd. (Taodian Avenue Division)

Data as of · How to read this entry

Registered sites
1
Active NDC listings
1
Live patents
0
Countries
1
Base
China
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Anhui Haoyuan Pharmaceutical Co., Ltd. (Taodian Avenue Division)No.155, Taodian Avenue, Cihu Hi-tech District, Maanshan, Anhui 243000, China (CHN)Active ingredient (API) manufacture3030636676456403445
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
-Calcipotrienepowder84937-965BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Neighbours

Registered in the same town

1
Compare

Comparable companies in China

Enquiry

Common questions

Is Anhui Haoyuan Pharmaceutical Co., Ltd. (Taodian Avenue Division) FDA approved?
Anhui Haoyuan Pharmaceutical Co., Ltd. (Taodian Avenue Division) holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Anhui Haoyuan Pharmaceutical Co., Ltd. (Taodian Avenue Division)'s drugs manufactured?
The FDA register lists Maanshan. Registered operations: active ingredient (API) manufacture.
What drugs does Anhui Haoyuan Pharmaceutical Co., Ltd. (Taodian Avenue Division) make?
1 product is listed under Anhui Haoyuan Pharmaceutical Co., Ltd. (Taodian Avenue Division) in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.